Santiago’s team showed that GZMA can be involved in tumor development and is a potential prognostic target for various cancers; this may be due to the ability of extracellular GZMA to promote the production of NF-κB-dependent IL6 in macrophages (25). This evidence concerns the gene NFKB1 and neoplasm.